Skip to content

Age Related Macular Degeneration Susceptibility To Cn322580

Published: July 22, 2026Updated: August 20, 2026

A genetic factor that may increase a person's risk for age-related macular degeneration. Regular eye exams are recommended for those with this susceptibility.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
H53.9
ICD-11
9A00.0
Body system
ophthalmologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Color vision abnormalities

(ophthalmologic)

Generalized symptoms

(ophthalmologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Blurry or fuzzy central vision

(ophthalmologic)

Slow adaptation to low light conditions

(ophthalmologic)

Dark or empty areas in central vision

(ophthalmologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

AREDS2 Supplement Protocol

Antioxidant and zinc supplementation following Age-Related Eye Disease Study 2 guidelines to reduce progression risk in patients with intermediate drusen or large drusen in one eye. These formulations contain specific combinations of vitamins C, E, zinc, copper, lutein, and zeaxanthin.

dietary
2

Behavioral and nutritional therapy

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

UV Protection and Smoking Cessation

Implementation of protective eyewear against UV radiation and complete smoking cessation, as smoking is a significant modifiable risk factor for AMD development and progression. Lifestyle modifications provide cumulative protective effects over time.

lifestyle

Additional treatment options

Regular Ophthalmologic Surveillance

Scheduled comprehensive eye examinations with dilation to monitor for conversion to advanced AMD, including optical coherence tomography and fundus autofluorescence imaging as appropriate for disease stage assessment.

monitoring

Mediterranean Diet Adherence

Adoption of Mediterranean-style dietary pattern rich in leafy green vegetables, fish, and olive oil to provide essential nutrients and anti-inflammatory compounds that may support retinal health and reduce oxidative stress.

dietary

Cardiovascular Risk Management

Control of hypertension, hypercholesterolemia, and other cardiovascular risk factors through coordinated care with primary physician, as vascular health is closely linked to ocular circulation and AMD risk.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Age Related Macular Degeneration Susceptibility To Cn322580?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

American Academy of Ophthalmology. Age-Related Macular Degeneration Preferred Practice Pattern. Ophthalmology. 2023.

guideline2023View source →
2

Mitchell P, Liew G, Buitendijk GH, et al. Update on Treatments for Age-Related Macular Degeneration. Prog Retin Eye Res. 2022.

review2022
3

Rong AJ, Swaminathan SS, Singh RP, et al. Anti-VEGF Therapy Outcomes in Neovascular AMD: A Meta-Analysis. JAMA Ophthalmol. 2021.

meta_analysis2021
4

Heier JS, Brown DM, Chong V, et al. Intravitreal Aflibercept for Treatment of Wet AMD: VIEW Trials. Lancet. 2020.

clinical_trial2020

Medication Comparisons

Compare medications used to treat Age Related Macular Degeneration Susceptibility To Cn322580. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy